Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell Tumors

NCT03726281 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped End of Agreement between BMS and SGHL

Conditions

Interventions

Sponsor

Hospital Beatriz Ângelo

Collaborators